Thomas C. Wright,
#164,088
Most Influential Person Now
Thomas C. Wright,'s AcademicInfluence.com Rankings
Thomas C. Wright,medical Degrees
Medical
#3356
World Rank
#3824
Historical Rank
Public Health
#527
World Rank
#544
Historical Rank
Epidemiology
#638
World Rank
#664
Historical Rank

Download Badge
Medical
Thomas C. Wright,'s Degrees
- PhD Epidemiology University of California, Berkeley
- Masters Public Health University of California, Berkeley
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Thomas C. Wright, Influential?
(Suggest an Edit or Addition)Thomas C. Wright,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. (2010) (2119)
- 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. (2002) (994)
- 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities (2002) (732)
- Cost-effectiveness of cervical-cancer screening in five developing countries. (2005) (673)
- Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. (2004) (577)
- The carcinogenicity of human papillomavirus types reflects viral evolution. (2005) (565)
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. (2007) (521)
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening (2004) (519)
- Incidence of cervical squamous intraepithelial lesions in HIV-infected women. (2000) (517)
- HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. (2000) (491)
- Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. (2011) (449)
- Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. (2001) (396)
- Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. (2015) (387)
- 2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests (2007) (358)
- Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. (2005) (355)
- Human papillomavirus infection in women infected with the human immunodeficiency virus. (1998) (351)
- 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. (2007) (350)
- High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. (2011) (316)
- Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. (2002) (279)
- Evaluation of alternative methods of cervical cancer screening for resource‐poor settings (2000) (275)
- Adding a test for human papillomavirus DNA to cervical-cancer screening. (2003) (270)
- Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. (2005) (253)
- Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus (1997) (250)
- 2006 Consensus Guidelines for the Management of Women With Cervical Intraepithelial Neoplasia or Adenocarcinoma In Situ (2007) (247)
- Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More (2004) (229)
- A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine (2003) (229)
- The ATHENA human papillomavirus study: design, methods, and baseline results. (2012) (228)
- 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. (2003) (228)
- Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of papanicolaou smears (1994) (227)
- Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. (1994) (225)
- Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. (1999) (222)
- Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. (2011) (213)
- Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. (2000) (213)
- The 2001 Bethesda System terminology. (2003) (200)
- Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. (2005) (199)
- Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. (2013) (195)
- Precancerous Lesions of the Cervix (1994) (193)
- Comparison of Management Algorithms for the Evaluation of Women With Low‐Grade Cytologic Abnormalities (1995) (184)
- HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study (2002) (179)
- The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. (1997) (176)
- Human Papillomavirus Infection in Human Immunodeficiency Virus–Seropositive Women (1995) (169)
- Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. (1992) (162)
- Treatment of Cervical Intraepithelial Neoplasia Using the Loop Electrosurgical Excision Procedure (1992) (156)
- Direct visual inspection for cervical cancer screening (2002) (147)
- Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. (2010) (133)
- Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. (2004) (128)
- Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. (2005) (127)
- Cervical human papillomavirus infection and intraepithelial neoplasia: a review. (1996) (127)
- Women's desired information about human papillomavirus (2004) (125)
- Primary Cervical Cancer Screening With Human Papillomavirus: End of Study Results From the ATHENA Study Using HPV as the First-Line Screening Test (2015) (120)
- Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. (1992) (119)
- Cervical Cancer Screening in the 21st Century: Is it Time to Retire the PAP Smear? (2007) (115)
- Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. (1998) (114)
- Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. (1994) (109)
- Controversies in the management of low‐grade cervical intraepithelial neoplasia (1993) (106)
- Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. (2007) (106)
- Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women (2010) (103)
- The 2001 Bethesda system: Terminology for reporting results of cervical cytology (2002) (99)
- Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. (1990) (98)
- Acceptability of self-collection of specimens for HPV DNA testing in an urban population. (2005) (97)
- Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. (2007) (96)
- Molecular biology of cervical cancer and its precursors (1995) (96)
- News media coverage of human papillomavirus (2004) (95)
- Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. (2006) (93)
- Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. (2001) (91)
- Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus (1997) (90)
- Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. (2017) (88)
- Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? (1998) (88)
- Distribution of Human Papillomavirus Genotypes among HIV-Positive and HIV-Negative Women in Cape Town, South Africa (2014) (88)
- Direct comparison of liquid‐based and conventional cytology in a South African screening trial (2006) (81)
- Alternative approaches to cervical cancer screening for developing countries. (2012) (81)
- Clinical Evaluation of the Cartridge-Based GeneXpert Human Papillomavirus Assay in Women Referred for Colposcopy (2014) (77)
- Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. (1996) (76)
- Interlaboratory variation in the performance of liquid‐based cytology: Insights from the ATHENA trial (2014) (76)
- Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV‐seropositive women (1996) (75)
- Carcinoma and Other Tumors of the Cervix (2019) (72)
- Characteristics of Menstruation in Women Infected With Human Immunodeficiency Virus (1996) (72)
- Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology. (1996) (69)
- Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. (2001) (69)
- Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. (2011) (69)
- Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. (1996) (68)
- Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. (1998) (68)
- Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. (2000) (66)
- Prevalence of Underlying Adenocarcinoma in Women with Atypical Endometrial Hyperplasia (2005) (64)
- Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. (2001) (62)
- Two-stage cervical cancer screening: an alternative for resource-poor settings. (2000) (61)
- Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. (2006) (60)
- APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results. (2013) (60)
- Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-Hispanic, black women. (1998) (59)
- Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study. (2015) (58)
- Nested Case–Control Study of Cervical Mucosal Lesions, Ectopy, and Incident HIV Infection Among Women in Cape Town, South Africa (2006) (56)
- Increased cervical cancer risk associated with screening at longer intervals. (2015) (56)
- Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests (2007) (55)
- Significance of mild cytologic atypia in women infected with human immunodeficiency virus (1996) (54)
- Age considerations when vaccinating against HPV. (2008) (53)
- A Polymerase Chain Reaction–Enzyme‐Linked Immunosorbent Assay Method for Detecting Human Papillomavirus in Cervical Carcinomas and High‐Grade Cervical Cancer Precursors (1995) (52)
- Intravaginal Practices, HIV and Other Sexually Transmitted Diseases Among South African Women (2004) (51)
- The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results. (2018) (48)
- Human papillomavirus testing and screening. (2005) (48)
- Chapter 14: HPV vaccine introduction in industrialized countries. (2006) (47)
- Cervical cancer screening in low‐resource settings: A cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage (2015) (47)
- The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study. (2012) (46)
- The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels (2011) (45)
- The costs of reducing loss to follow-up in South African cervical cancer screening (2005) (44)
- Human immunodeficiency virus infection and female lower genital tract malignancy. (1999) (42)
- Evaluating HPV‐negative CIN2+ in the ATHENA trial (2016) (42)
- Comparison of specimens removed by CO2 laser conization and the loop electrosurgical excision procedure. (1992) (41)
- CHAPTER 3 Pathology of HPV infection at the cytologic and histologic levels: Basis for a 2‐tiered morphologic classification system (2006) (41)
- Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population. (2015) (41)
- Human Papillomavirus (HPV) Detection Among Human Immunodeficiency Virus–Infected Pregnant Thai Women: Implications for Future HPV Immunization (2006) (38)
- Treating vaginal and external anogenital condylomas with electrosurgery vs CO2 laser ablation. (1995) (37)
- Oral contraceptive and benign ovarian tumors. (2000) (37)
- Pearly Penile Papules: Absence of Human Papillomavirus DNA by the Polymerase Chain Reaction (1991) (36)
- HPV DNA Testing for Cervical Cancer Screening (2006) (36)
- Assessment of the Cervix After Acetic Acid Wash: Inter‐Rater Agreement Using Photographs (2002) (35)
- Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens. (2014) (34)
- Chapter 10: Cervical cancer screening using visualization techniques. (2003) (34)
- Cervical cancer screening using visualization techniques (2003) (34)
- Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol. (2004) (32)
- Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study. (2015) (31)
- Anogenital papillomavirus infection and neoplasia in immunodeficient women. (1996) (31)
- Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. (1995) (31)
- Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. (2020) (30)
- Use of visual screening methods for cervical cancer screening. (2002) (30)
- Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology. (2019) (29)
- Invasive vulvar carcinoma in two women infected with human immunodeficiency virus. (1996) (29)
- Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology. (2019) (29)
- Increased detection of high-grade cervical intraepithelial neoplasia utilizing an optical detection system as an adjunct to colposcopy. (2007) (29)
- Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients. (1996) (28)
- Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. (2020) (28)
- Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA (2019) (27)
- HPV vaccine introduction in industrialized countries (2006) (27)
- Natural history of HPV infections. (2009) (26)
- Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus‐18 (1995) (26)
- X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. (1995) (26)
- Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. (2006) (25)
- Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics (2017) (25)
- Measuring cervical ectopy: direct visual assessment versus computerized planimetry. (1997) (24)
- Distribution of High-Risk Human Papillomavirus Genotypes among HIV-Negative Women with and without Cervical Intraepithelial Neoplasia in South Africa (2012) (24)
- A comparison of human papillomavirus testing of clinician‐collected and self‐collected samples during follow‐up after screen‐and‐treat (2011) (23)
- Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study (2018) (22)
- Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. (1999) (22)
- Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas. (1993) (21)
- Can cervicography be improved? An evaluation with arbitrated cervicography interpretations. (2002) (21)
- Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa (2010) (20)
- Loop excision of the uterine cervix. (1995) (20)
- The budget impact of cervical cancer screening using HPV primary screening. (2016) (19)
- Human papillomavirus testing in primary cervical screening (1995) (19)
- Amplification of the 3q chromosomal region as a specific marker in cervical cancer. (2015) (19)
- Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study. (2016) (18)
- Comparison of CO2 laser surgery and loop electrosurgical excision/fulguration procedure (LEEP) for the treatment of vulvar intraepithelial neoplasia (VIN) (1993) (17)
- Recurrence of symptomatic bacterial vaginosis 12 months after oral metronidazole therapy in HIV-positive and -negative women. (2006) (17)
- Is viral status needed before vaccination? (2008) (16)
- Cigarette smoking and cervical dysplasia among non-Hispanic black women. (1998) (16)
- Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa (2005) (16)
- Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population (2018) (15)
- Loop electrosurgical excision procedure for CIN. (1992) (15)
- Cervical cancer prevention for all the world's women: New approaches offer opportunities and promise (2007) (15)
- Preliminary experimental results from multi-center clinical trials for detection of cervical precancerous lesions using the Cerviscan/spl trade/ system: a novel full-field evoked tissue fluorescence based imaging instrument (2001) (15)
- Analysis of lower genital tract lesions clinically suspicious for condylomata using in situ hybridization and the polymerase chain reaction for the detection of human papillomavirus. (1994) (14)
- HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trial. (2019) (14)
- Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico (2016) (13)
- Cervical cancer prevention using visual screening methods (1999) (13)
- Detection of Infectious Human Immunodeficiency Virus Type 1 in Female Genital Secretions by a Short-Term Culture Method (2003) (13)
- 2001 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia (2003) (12)
- Oral Contraceptives and Benign Ovarian Tumors (2001) (12)
- Epithelial Cell Abnormalities: Squamous (2015) (12)
- HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. (2006) (12)
- Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa (2020) (11)
- Managing abnormal cytology results in pregnancy. (2005) (11)
- Performance of an Human Papillomavirus Test in Samples From Women With Histolopathologically Confirmed Invasive Cervical Cancer (2016) (11)
- HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology (2019) (11)
- Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women (2020) (11)
- Estradiol-Induced Hyperplasia in Endometrial Biopsies From Women on Hormone Replacement Therapy (2002) (11)
- Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study. (2001) (10)
- Erratum: Cervical cancer control, priorities and new directions (International Journal of Cancer (2003) 108 (329-333)) (2004) (9)
- Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial (2021) (9)
- Clonal expansion and HPV-induced immortalization are early molecular alterations in cervical carcinogenesis. (2003) (7)
- South African women's perspectives on self-sampling for cervical cancer screening: A mixed-methods study. (2018) (7)
- Pathology of the cervix (1991) (7)
- Human Immunodeficiency Virus Infection of Early Passage Cervical Epithelial Cultures (1993) (7)
- Cervical cancer prevention - a paradigm shift? (2005) (7)
- Alliance for cervical cancer prevention: setting the record straight. (2007) (7)
- Adjunctive HPV In-Situ Hybridization (ISH) Assay as an Aid in the Diagnosis of Cervical Intraepithelial Neoplasia in Cervical Tissue Specimens: An Analytical and Functional Characterization (2012) (6)
- Primary Cervical Cancer Screening With Human Papillomavirus (2015) (6)
- PIN37 A COMPREHENSIVE NATURAL HISTORY MODEL OF HUMAN PAPILLOMAVIRUS (HPV) INFECTION AND CERVICAL CANCER: POTENTIAL IMPACT OF AN HPV 16/18 VACCINE (2002) (6)
- Atypical glandular cells (AGC): ThinPrep Imaging System (TIS), manual screening (MS), and correlation with Hybrid Capture 2 (HC2) HPV DNA testing (2009) (6)
- Screening for cervical cancer. (2000) (6)
- Correlation of Human Immunodeficiency Virus Type 1 RNA Levels in Blood and the Female Genital Tract (1999) (5)
- Bacterial Vaginosis and Susceptibility to HIV Infection in South African Women: A Nested (2005) (5)
- Cervical cancer screening strategies for developing countries. Symposium. (2001) (5)
- The IMPACT trial: human papillomavirus, cervical cytology and histopathological results from the baseline and 1-year follow-up phase. (2021) (5)
- A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers (2020) (5)
- Prevention of cervical cancer in low-resource settings. Authors' reply (2006) (4)
- What you need to know about cervical cancer, genital warts, and HPV (2007) (4)
- High-grade uterine sarcoma during pregnancy. (2011) (3)
- Infiltrating adenomyosis of the cervix with features of a low-grade stromal sarcoma: a case report and a literature review. (2014) (2)
- HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer (2000) (2)
- Adjunctive p16 Immunohistochemistry Use in Cervical Biopsies According to LAST Criteria (2021) (2)
- The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions. (2002) (2)
- Prospects for cervical screening in developing countries (2000) (2)
- Cervical cancer screening in non-industrialised countries (2003) (2)
- Cytological features of choricarcinoma in a Pap smear: A case report and literature review (2016) (2)
- Outpatient surgery in gynecologic oncology (1993) (2)
- The New ASCCP Colposcopy Standards. (2017) (1)
- B‐cell lymphoma of the vagina occurring after treatment for classic Hodgkin lymphoma: A case report and literature review (2013) (1)
- The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase (2021) (1)
- Clinical utility of reflex testing with cancer biomarkers to improve diagnostic accuracy of primary Human Papillomavirus screening. (2022) (1)
- Loop Electrosurgical Excision Procedure for Treating Cervical Intraepithelial Neoplasia (2011) (1)
- Prevention of Cervical Cancer in Low-Resource Settings—Reply (2006) (1)
- The CERTAIN Study Results (2021) (1)
- Management of Women with High-Grade Squamous Intraepithelial Lesion and Atypical Glandular Cell Cervical Cytology (2006) (1)
- Immunosuppression and the Cervix: Human Immunovirus (HIV) (2009) (1)
- Risk of ≥ CIN3 after 3 years of follow-up of 42,209 screened women: End of study results from ATHENA (2013) (1)
- HPV Testing of Self-Collected Vaginal Swabs for Cervical Cancer Prevention in South Africa (2016) (1)
- Preliminary results from multicenter clinical trials for detection of cervical squamous intraepithelial lesions using a novel full-field evoked-tissue-flourescence-based imaging instrument (2001) (1)
- A Local and Global Perspective on Cervical Screening with HPV - An Educational Forum (2014) (0)
- Nephrology Dialysis Transplantation Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients (2005) (0)
- HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy (2015) (0)
- Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: Results from the ATHENA trial 3-year follow-up phase (2014) (0)
- HPV Oncogenic mRNA testing for Cervical Cancer Screening ; Baseline and Longitudinal 2 Results from the CLEAR Study 3 4 (2014) (0)
- Treatment of CIN using the loop electrodiathermy excision procedure (1991) (0)
- Errata (2002) (0)
- PCR-Based quantification of replication-competent HIV-1 in female genital secretions (2001) (0)
- Errata (2003) (0)
- Human papillomavirus. (2019) (0)
- Reflex Human Papillomavirus Deoxyribonucleic Acid Testing in Women with Abnormal Papanicolaou Smears (1998) (0)
- Diagnosis of adenocarcinoma in situ (AIS): Changing trends and the impact of human papillomavirus (HPV) testing (2014) (0)
- Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial. (2023) (0)
- The Management of Women with Atypical Squamous Cells (2008) (0)
- ARness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy (2005) (0)
- Human papillomavirus in adenocarcinomas of the endocervix detected using the polymerase chain reaction (1992) (0)
- PCN3 POTENTIAL IMPACT OF WANING OF VACCINE-INDUCED IMMUNITY AGAINST HUMAN PAPILLOMAVIRUS 16/18 (2004) (0)
- Use of the Long-Acting Injectable Contraceptive Depo Provera and Integrity of the Cervical Epithelium (1998) (0)
- Comparison of CO2 Laser Surgery and Loop Electrosurgical Excision/ Fulguration Procedure for the Treatment of Vulvar Intraepithelial Neoplasia (1994) (0)
- Abstract B77: High-risk human papillomavirus genotypes among HIV-negative black women with or without cervical disease in South Africa (2010) (0)
- Detection of Ki-ras mutations in endocervical adenocarcinomas by polymerase chain reaction (1992) (0)
- HIV Infection in Women (2001) (0)
- Performance of an Human Papillomavirus Test in Samples From Women With Histopathologically Confirmed Invasive Cervical Cancer. (2016) (0)
- Prevention of cervical cancer in low-resource settings. In reply [letter] (2006) (0)
- Editorial: Identifying gaps in the knowledge base underlying cervical cytology guidelines (2002) (0)
- HPV DNA positivity and cytologic abnormalities in anal intraepithelial neoplasia of HIV-infected and uninfected women (2007) (0)
- PIN18 PROJECTED CLINICAL BENEFITS AND COSTEFFECTIVENESS OF AN HPV 16/18 VACCINE (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas C. Wright,?
Thomas C. Wright, is affiliated with the following schools: